Hu, X. & Guo, F. Amino acid sensing in metabolic homeostasis and health. Endocr. Rev. 42, 56–76 (2021).
Google Scholar
Jouandin, P. et al. Lysosomal cystine mobilization shapes the response of TORC1 and tissue growth to fasting. Science 375, eabc4203 (2022).
Google Scholar
Cangelosi, A. L. et al. Zonated leucine sensing by Sestrin-mTORC1 in the liver controls the response to dietary leucine. Science 377, 47–56 (2022).
Google Scholar
Gu, X. et al. Sestrin mediates detection of and adaptation to low-leucine diets in Drosophila. Nature 608, 209–216 (2022).
Google Scholar
Chen, J. et al. SAR1B senses leucine levels to regulate mTORC1 signalling. Nature 596, 281–284 (2021).
Google Scholar
Chen, J. et al. KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing. Nature 557, 585–589 (2018).
Google Scholar
Bar-Peled, L. et al. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100–1106 (2013).
Google Scholar
Greten, F. R. & Grivennikov, S. I. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51, 27–41 (2019).
Google Scholar
Bader, J. E. et al. Obesity induces PD-1 on macrophages to suppress anti-tumour immunity. Nature 630, 968–975 (2024).
Google Scholar
Memon, D. et al. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer. Cancer Cell 42, 209–224.e9 (2024).
Google Scholar
Thiem, S. et al. mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J. Clin. Invest. 123, 767–781 (2013).
Google Scholar
Lee, D.-F. et al. IKK β suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130, 440–455 (2007).
Google Scholar
Groessl, S. et al. Acidosis orchestrates adaptations of energy metabolism in tumors. Science 390, eadp7603 (2025).
Google Scholar
Bian, Y. et al. Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature 585, 277–282 (2020).
Google Scholar
Guo, C. et al. SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity. Nature 620, 200–208 (2023).
Google Scholar
Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183–203 (2020).
Google Scholar
Napolitano, G. et al. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome. Nature 585, 597–602 (2020).
Google Scholar
Chen, C., Liu, Y., Liu, Y. & Zheng, P. Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice. J. Clin. Invest. 120, 4091–4101 (2010).
Google Scholar
Shultz, L. D. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477–6489 (2005).
Google Scholar
Burr, M. L. et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature 549, 101–105 (2017).
Google Scholar
Bianchi, L. et al. Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. Neurochem. Res. 29, 325–334 (2004).
Google Scholar
Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. eLife 8, e44235 (2019).
Google Scholar
Szabo, P. A. et al. Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease. Nat. Commun. 10, 4706 (2019).
Google Scholar
Hoekstra, M. E. et al. Distinct spatiotemporal dynamics of CD8+ T cell-derived cytokines in the tumor microenvironment. Cancer Cell 42, 157–167.e9 (2024).
Google Scholar
Mlak, R. et al. The relationship between TNF-α gene promoter polymorphism (−1211 T > C), the plasma concentration of TNF-α, and risk of oral mucositis and shortening of overall survival in patients subjected to intensity-modulated radiation therapy due to head and neck cancer. Support. Care Cancer 28, 531–540 (2020).
Google Scholar
Siegmund, D. & Wajant, H. TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond. Nat. Rev. Rheumatol. 19, 576–591 (2023).
Google Scholar
Sun, Y. et al. Targeting TBK1 to overcome resistance to cancer immunotherapy. Nature 615, 158–167 (2023).
Google Scholar
Young, T. M. et al. Autophagy protects tumors from T cell-mediated cytotoxicity via inhibition of TNF-induced apoptosis. Sci. Immunol. 5, eabb9561 (2020).
Google Scholar
Koo, G.-B. et al. Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res. 25, 707–725 (2015).
Google Scholar
Yuan, S. et al. VDAC2 loss elicits tumour destruction and inflammation for cancer therapy. Nature 640, 1062–1071 (2025).
Google Scholar
Shen, K. et al. Architecture of the human GATOR1 and GATOR1-Rag GTPases complexes. Nature 556, 64–69 (2018).
Google Scholar
Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496–1501 (2008).
Google Scholar
Dai, X. et al. AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation. Nat. Metab. 5, 265–276 (2023).
Google Scholar
Jiang, C. et al. Ring domains are essential for GATOR2-dependent mTORC1 activation. Mol. Cell https://doi.org/10.1016/j.molcel.2022.11.021 (2022).
Pintard, L., Willems, A. & Peter, M. Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. EMBO J. 23, 1681–1687 (2004).
Google Scholar
Mathew, R. et al. BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. Nature 491, 618–621 (2012).
Google Scholar
Lawrence, R. E. & Zoncu, R. The lysosome as a cellular centre for signalling, metabolism and quality control. Nat. Cell Biol. 21, 133–142 (2019).
Google Scholar
Kim, J. & Guan, K.-L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol. 21, 63–71 (2019).
Google Scholar
Wyant, G. A. et al. NUFIP1 is a ribosome receptor for starvation-induced ribophagy. Science 360, 751–758 (2018).
Google Scholar
Huttlin, E. L. et al. Architecture of the human interactome defines protein communities and disease networks. Nature 545, 505–509 (2017).
Google Scholar
Gu, X. et al. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science 358, 813–818 (2017).
Google Scholar
Eskelinen, E.-L. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects Med. 27, 495–502 (2006).
Google Scholar
Wolfson, R. L. et al. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature 543, 438–442 (2017).
Google Scholar
Peng, M., Yin, N. & Li, M. O. SZT2 dictates GATOR control of mTORC1 signalling. Nature 543, 433–437 (2017).
Google Scholar
Koh, D.-I. et al. A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene. J. Biol. Chem. 284, 19856–19866 (2009).
Google Scholar
Choi, S.-H. et al. Cell fate decisions by c-Myc depend on ZBTB5 and p53. Biochem. Biophys. Res. Commun. 533, 1247–1254 (2020).
Google Scholar
Hunter, T. Why nature chose phosphate to modify proteins. Philos. Trans. R. Soc. Lond. B 367, 2513–2516 (2012).
Google Scholar
Johnson, J. L. et al. An atlas of substrate specificities for the human serine/threonine kinome. Nature 613, 759–766 (2023).
Google Scholar
Arthur, J. S. C. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679–692 (2013).
Google Scholar
Schmitz, M. L. & Kracht, M. Cyclin-dependent kinases as coregulators of inflammatory gene expression. Trends Pharmacol. Sci. 37, 101–113 (2016).
Google Scholar
Arner, E. N. & Rathmell, J. C. Metabolic programming and immune suppression in the tumor microenvironment. Cancer Cell 41, 421–433 (2023).
Google Scholar
Su, H. et al. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature 610, 366–372 (2022).
Google Scholar
Alexander, S. P. H. et al. The concise guide to pharmacology 2019/20: transporters. Br. J. Pharmacol. 176, S397–S493 (2019).
Google Scholar
Bacci, M. et al. Reprogramming of amino acid transporters to support aspartate and glutamate dependency sustains endocrine resistance in breast cancer. Cell Rep. 28, 104–118.e8 (2019).
Google Scholar
Wang, L. et al. Intestinal subtype as a biomarker of response to neoadjuvant immunochemotherapy in locally advanced gastric adenocarcinoma: insights from a prospective phase II trial. Clin. Cancer Res. 31, 74–86 (2025).
Google Scholar
Long, L. et al. CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity. Nature 600, 308–313 (2021).
Google Scholar
Ando, S. et al. mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection. J. Clin. Invest. 133, e160025 (2023).
Google Scholar
Huang, C. et al. EZH2-triggered methylation of SMAD3 promotes its activation and tumor metastasis. J. Clin. Invest. 132, e152394 (2022).
Google Scholar
Li, J. et al. A cell-penetrating PHLPP peptide improves cardiac arrest survival in murine and swine models. J. Clin. Invest. 133, e164283 (2023).
Google Scholar
Gan, W. et al. LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. Nat. Cell Biol. 22, 246–256 (2020).
Google Scholar
Cao, T. et al. Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells. Cell 187, 2288–2304.e27 (2024).
Google Scholar
Cui, C. et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis. Cell 184, 3163–3177.e21 (2021).
Google Scholar
Xiang, J. Immunohistochemistry and immunofluorescence protocols v1. Protocols.io https://doi.org/10.17504/protocols.io.ewov1ko5kgr2/v1 (2026).
You, K. et al. QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis. Science 371, eabb6896 (2021).
Google Scholar
Xiang, J. Mass spectrometry analyses v1. Protocols.io https://doi.org/10.17504/protocols.io.eq2ly579rvx9/v1 (2026).
Li, C. et al. Amino acid catabolism regulates hematopoietic stem cell proteostasis via a GCN2-eIF2α axis. Cell Stem Cell 29, 1119–1134.e7 (2022).
Google Scholar
Liu, X. et al. Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer. Nature 588, 693–698 (2020).
Google Scholar
Cattaneo, C. M. et al. Tumor organoid-T-cell coculture systems. Nat. Protoc. 15, 15–39 (2020).
Google Scholar
Tian, F. RNA sequencing (RNA-seq) and analysis v1. Protocols.io https://doi.org/10.17504/protocols.io.8epv55jkjv1b/v1 (2026).
Qin, J. et al. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis. Nature 493, 236–240 (2013).
Google Scholar
